A naturally occurring copper peptide that acts like a master switch for your body's repair systems—boosting collagen production, accelerating wound healing, and helping your skin rebuild itself from the inside out [1][4].
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Subcutaneous
Route
4 recommended
Sites
Once or twice daily, topical
Frequency
Preparation
Bacteriostatic water (BAC water)—the preservative keeps it safe for multiple uses
Insulin syringes (29-31 gauge)—thin needles for minimal discomfort
Alcohol swabs for cleaning vial tops and injection sites
Your GHK-Cu powder vial (may have a slight blue tint from the copper)
Pro tip
Prepare all supplies on a clean surface before you begin. Having everything ready makes the process smoother and more sterile.
Mixing
Wash your hands thoroughly with soap and water. Gather all supplies on a clean, flat surface.
Remove the plastic cap from the peptide vial and wipe the rubber stopper with an alcohol swab. Let it air dry.
Draw the appropriate amount of bacteriostatic water into a sterile syringe.
Insert the needle into the vial at an angle, aiming at the inside wall of the vial. Slowly push the plunger to let the water trickle down the glass wall -- do NOT squirt directly onto the powder.
Once all water is added, gently swirl the vial in a slow circular motion. Never shake the vial, as this can damage the peptide bonds.
Continue swirling until the powder is completely dissolved and the solution is clear. If particles remain, let the vial sit for a few minutes and swirl again.
Label the vial with the date of reconstitution, the peptide name, and the concentration (e.g. 250mcg per 0.1mL).
Example calculation
Most research vendors sell GHK-Cu in 50mg vials. Add 5mL of bacteriostatic water to a 50mg vial for a 10mg/mL concentration — every 0.1mL (10 units on an insulin syringe) equals 1mg of GHK-Cu. For a smaller 5mg vial, add 2.5mL of BAC water for 2mg/mL, where 0.5mL (50 units) equals 1mg.
Dose calculation
For a 2mg subcutaneous dose from a 50mg vial at 10mg/mL: draw 0.2mL (20 units on a standard insulin syringe). The solution may have a faint blue tint — that's the copper ion, and it's normal.
Pro tip
Always add the bacteriostatic water slowly, letting it run down the side of the vial. Never shake the vial -- swirl gently to avoid damaging the peptide.
Location
Site 01
Abdomen
Pinch the skin 2 inches from navel. Avoid the area directly around the belly button. Rotate between left and right sides.
Site 02
Outer Thigh
Middle third of the outer thigh. Keep at least 4 inches above the knee and below the hip. Alternate legs each injection.
Site 03
Near the target area if treating a specific wound or scar (inject nearby, not directly into it)
Follow your provider's instructions for this injection site. Rotate sites regularly to prevent tissue damage.
Site 04
Upper Arm
Back or outer area of the upper arm. This site may require assistance from another person for proper technique.
Rotate between 4 sites to prevent tissue buildup and ensure consistent absorption.
Pro tip
Rotate your injection sites with each dose to prevent lipohypertrophy (buildup of fatty tissue). Keep a simple log of where you last injected.
Step by step
Wash your hands thoroughly with soap and water
Clean the injection site with an alcohol swab and let it air dry
Pinch about an inch of skin to create a fold
Insert the needle at a 45-90 degree angle (45 if lean, 90 if more tissue)
Push the plunger slowly and steadily—rushing can cause more discomfort
Wait 5 seconds before withdrawing the needle
Apply gentle pressure with a clean cotton ball if needed—don't rub
Pro tip
This peptide uses subcutaneous injection (just under the skin)—the most common method. can also be applied topically for localized skin benefits.. Inject at a 45-90 degree angle into pinched skin. Aspirate before injecting to ensure you haven't hit a blood vessel.
Timing
Optimal timing
Best time
Morning injections work well for GHK-Cu since it supports daytime repair processes. If using topically, apply at night so your skin can absorb it while you sleep and repair overnight.
With food?
GHK-Cu injections aren't affected by food timing, so inject whenever is convenient. If you're taking oral copper or zinc supplements, space them at least 2 hours from each other.
Stacking notes
GHK-Cu pairs beautifully with BPC-157 for a comprehensive healing stack. If injecting multiple peptides, use different injection sites and space them 15-30 minutes apart. For an anti-aging combo, pair with Epithalon—they work through completely different mechanisms.
Sample daily schedule
Morning (7-9 AM)
1-3 mg depending on protocol tier injection
Site: Rotate between belly, thigh, and arm (or near target area for localized healing)
Morning dosing supports your body's natural daytime repair processes. Rotate injection sites daily to prevent tissue irritation. If using for skin anti-aging, some practitioners prefer injecting in areas close to the face/neck for localized benefit.
Dosing tiers
Dose
0.1% cream (roughly 1 mg/mL)
Frequency
Once or twice daily to the treatment area
Duration
12 weeks for visible results, then ongoing
This is the only GHK-Cu route with a controlled human trial behind it, and the trial was largely negative. Thirteen patients used a GHK-Cu aftercare regimen after CO2 laser resurfacing; blinded assessment found no significant improvement in redness, wrinkles or overall skin quality versus the control regimen, and only the patients' own rating separated (P = 0.04) [7]. Topical wound-healing evidence beyond that is animal — 24 rats with ischemic wounds, where the copper tripeptide gel reduced wound area faster than vehicle [4]. Concentration matters and is not standardised across products; the figures quoted for cosmetic creams come from industry reports rather than independent trials [1][2].
Dose
No established human dose
Frequency
Not established
Duration
Not established
There are no human studies of injected GHK-Cu by any systemic route. The GHK-Cu studies registered on ClinicalTrials.gov are topical or transdermal [13]. The 1-2 mg figures circulated for subcutaneous use trace to community practice, not to any published study, and no human toxicology exists for the copper load a systemic dose would deliver. The Pickart literature most often cited for GHK-Cu is mechanistic and wound-repair work, not injectable dosing [1][2][3].
Preservation
Before mixing
Keep your GHK-Cu powder in the refrigerator (36-46°F / 2-8°C) for short-term storage or in the freezer (-4°F / -20°C) for long-term storage. Store in the original sealed vial away from light. The powder may appear white to very faintly blue. Properly stored powder remains stable for 2+ years when frozen.
After mixing
Once mixed with bacteriostatic water, refrigerate at 36-46°F (2-8°C). Never freeze the reconstituted solution. The solution should be clear with a possible faint blue tint. Keep away from light and use within 28 days.
Shelf life after mixing
28 days
Signs of degradation
Discard the vial immediately if you notice any of these:
Solution turns dark blue or greenish (faint blue is normal, dark is not)
Cloudiness or visible particles floating in the solution
Any unusual smell—fresh solution should have little to no odor
Precipitate or crystals forming at the bottom of the vial
Important
When to stop
Any signs of allergic reaction—stop immediately and get medical help
Persistent metallic taste that doesn't go away (possible copper excess)
Injection site reactions that spread, worsen, or show signs of infection
Nausea or stomach upset that persists beyond the first few days
Unusual skin discoloration away from injection sites
Your treatment goals have been achieved and you're in maintenance mode
GHK-Cu is a research compound, not an FDA-approved medication. Always consult with a qualified healthcare provider before starting, stopping, or adjusting any peptide protocol. This information is for educational purposes only—not medical advice.
Clean technique checklist
Wash hands thoroughly with soap and water before handling supplies
Swab vial tops and injection site with alcohol and let dry
Never touch the needle tip or allow it to contact non-sterile surfaces
Use a new syringe and needle for each injection
Dispose of used sharps in a proper sharps container
Store reconstituted peptides according to the storage instructions above
Published research
Pickart L · 2008
This comprehensive review showed GHK-Cu activates a wide range of tissue repair processes—attracting repair cells, boosting collagen and elastin, increasing blood vessel growth factors (VEGF), and stimulating hair follicle enlargement. In studies on aged skin, it tightened loose skin and improved elasticity.
Pickart L, Margolina A · 2018
Gene analysis revealed GHK-Cu influences over 4,000 human genes—about 6% of the entire genome. It upregulates collagen, elastin, and tissue repair genes while suppressing inflammation and promoting DNA repair. It's one of the most broadly-acting regenerative peptides known.
Pickart L, Vasquez-Soltero JM, Margolina A · 2014
GHK was found to reset gene expression patterns of diseased cells (including cancer and COPD cells) back toward healthier states. It increased cellular 'stemness' and activated multiple repair pathways simultaneously—suggesting it works as a broad biological reset signal.
Canapp SO, Farese JP, Schultz GS, Gowda S, et al. · 2003
Topical GHK-Cu dramatically accelerated wound healing—wounds shrank by 64.5% in the treatment group versus only 28.2% in controls by day 13. It also significantly reduced inflammatory markers TNF-alpha and destructive enzymes MMP-2/MMP-9.
Choi HR, Kang YA, Ryoo SJ, Shin JW, et al. · 2012
GHK increased the number of stem cells in skin tissue and boosted their ability to multiply. It worked by increasing integrin expression—the 'anchor proteins' that keep stem cells in their regenerative niche. This explains part of how GHK-Cu rejuvenates aging skin.
Simeon A, Monier F, Emonard H, Gillery P, et al. · 1999
GHK-Cu was shown to intelligently regulate wound remodeling enzymes (MMPs)—increasing them when needed for tissue restructuring and decreasing them to prevent excessive breakdown. This 'smart regulation' helps explain why GHK-Cu improves scar quality.
Miller TR, Wagner JD, Baack BR, Eisbach KJ · 2006
A randomized human trial of topical GHK-Cu, and the only controlled human trial of it indexed in PubMed. Thirteen patients who had circumoral CO2 laser resurfacing were randomized to an aftercare regimen with or without GHK-Cu. Blinded evaluators and computer analysis found no significant difference between the groups in how fast redness resolved, and no significant improvement in wrinkles or overall skin quality. Everyone improved; the GHK-Cu group did not improve more. The one measure that did separate was the patients' own rating of overall skin quality (P = 0.04).
Pickart L, Vasquez-Soltero JM, Margolina A · 2015
This review documents that GHK is present in human plasma, saliva, and urine, and that plasma levels fall from about 200 ng/mL at age 20 to about 80 ng/mL by age 60. It reports GHK's copper binding constant as log10 = 16.44, with the copper(II) ion coordinated by the histidine imidazole nitrogen, the alpha-amino nitrogen of glycine, and a deprotonated amide nitrogen. It also summarizes animal studies in which GHK injected at a site distant from the wound, or injected intraperitoneally, produced wound healing throughout the body.
Deng M, Zhang Q, Yan L, Bian Y, et al. · 2023
In mice with smoke-induced muscle damage, GHK-Cu given by intraperitoneal injection (0.2 or 2 mg/kg weekly for 7 weeks) reduced muscle loss and improved grip strength, showing that injected GHK-Cu reaches and acts on tissue away from the injection site. In people with COPD, plasma GHK was lower than in age-matched healthy subjects (70.3 vs 133.0 ng/mL).
Pickart L, Vasquez-Soltero JM, Margolina A · 2012
This review describes GHK as acting by delivering copper into the cell in a form that is non-toxic and usable by the cell, rather than as free copper ion. It also reports GHK's copper binding constant (log10 = 16.44) and the coordination of copper by the histidine imidazole nitrogen.
Borkow G · 2014
This review sets out the copper-dependent enzymes of skin: copper is a cofactor of superoxide dismutase (antioxidant defense), of lysyl oxidase (needed for cross-linking of extracellular matrix proteins such as collagen and elastin), and of tyrosinase (melanin synthesis). It notes that Cu-GHK, found in human serum, binds copper strongly and increases collagen and elastin synthesis.
Gruchlik A, Chodurek E, Dzierzewicz Z · 2014
In cultured normal human dermal fibroblasts, 1 nM GHK and 1 nM GHK-Cu both lowered the IGF-2-driven increase in TGF-beta1 secretion measured by ELISA. The authors note TGF-beta1's role in scar tissue formation and suggest the peptide may be useful in treating and preventing hypertrophic scars.
ClinicalTrials.gov registry record · 2026
The only interventional GHK-Cu trial currently registered on ClinicalTrials.gov, and it is topical: a Phase 2 study of a GHK-Cu gel applied to acute skin wounds, listed as recruiting. Searching the registry for "GHK-Cu" or "copper tripeptide" returns this study and one transdermal patch study; no registered trial gives GHK-Cu by injection.
Mateescu DM, Gavrilescu DM, Mincioaga RI, Pah AM, et al. · 2026
Systematic evidence-mapping review (Pharmaceutics 2026; full text PMC13610439). Its comparison table describes GHK-Cu as an endogenous tripeptide and the reference entity among copper peptides, with the best-characterized coordination and broadest multimodal dataset, while the synthetic analogue AHK-Cu carries cosmetic hair and skin claims on a thin, poorly characterized evidence base. The review also states that human clinical evidence for GHK-Cu remains sparse (a 13-participant post-CO2-laser study was negative on objective endpoints), that no validated GHK-Cu-specific human NOAEL or labile-copper safety threshold exists, that dietary copper limits (EFSA 5 mg/day; US upper limit 10 mg/day) cannot be converted directly into parenteral limits, and that the Cu(II) complex has a visible d-d absorption band at 580-600 nm used to confirm complex formation.
Liu T, Liu Y, Zhao X, Zhang L, et al. · 2024
Formulation study of topical GHK-Cu delivery for hair growth (Bioact Mater 2024; full text PMC10643103). Describes copper peptides (GHK-Cu) as complexes of the GHK tripeptide with divalent copper, and states that copper peptides have a blue color and that the amount of copper peptide can be estimated from the hue of the system.
Najafi N, Maatouk H, Vardanyan KG, Vartanian KB, Agrawal DK · 2026
Systematic review (Arch Intern Med Res 2026; NIH author manuscript PMC13604022). States that GHK-Cu is widely used in post-procedural cosmetic dermatology and that copper tripeptide-containing creams have been part of post-laser, post-Mohs, post-microneedling and post-hair-transplant care regimens for nearly two decades, while the published randomized-trial base for surgical indications is small; the one randomized post-CO2-laser trial found no objective benefit but higher patient satisfaction.
Head to head